Nearly 1 out of 8 European women will be affected by a breast cancer during her life.

The main surgical intervention to cure breast cancer today is mastectomy (73%) which remains a complicated intervention, often leading to a loss of self-esteem, sexual issues as well as a need for body acceptance. Only 20% of these women benefit from a breast reconstruction, either with silicone implants or transplants of tissues, requiring several interventions and presenting clinical risks and hurdles.

MAT(T)ISSE project aims to address these clinical challenges by developing, with the support of a multidisciplinary partnership across France and Belgium, a brand new solution for breast reconstruction. The innovation will consist of a 3D-printed bioresorbable and textile matrix to facilitate the transplant of tissues, as well as to guide the breast reconstruction process. This breakthrough innovation opens the way for a personalised and safer breast reconstruction, in a single intervention.

Research and process optimization activities conducted under MAT(T)ISSE project represent a gateway to further developments for various medical applications. As of 2020, the European regulatory framework for medical devices will be reinforced and specified to better frame the custom-made medical devices market.

MAT(T)ISSE partners are delighted to invite you to our 1st workshop: Make sure to anticipate these regulatory changes to participate to the ongoing revolution in implants!